SCHEMBL16280596

SCHEMBL16280596

Cn1c(-c2cccc(Cl)c2[S+]([O-])C(=O)[C@@H](N)CO)nc2cc(C(F)(F)F)cnc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.39
▸ AGPAT2 O15120 1/20 0.35
▸ PDE2A O00408 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ MET P08581 1/20 0.34
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ RECQL P46063 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 4/20 0.32
▸ HTT P42858 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ RORC P51449 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ DRD3 P35462 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16280594 1.00 POLB (0.39) POLBAGPAT2PDE2APDE10AMET
SCHEMBL15412515 0.81 POLB (0.41) POLBAGPAT2PDE2APDE10AMET
SCHEMBL16280595 0.76 POLB (0.39) POLBAGPAT2METRORCKDM4E
SCHEMBL15411977 0.74 POLB (0.43) POLBAGPAT2PDE2APDE10AMET
SCHEMBL15412037 0.71 POLB (0.46) POLBAGPAT2PDE2APDE10AMET
SCHEMBL10280746 0.71 PDE2A (0.42) POLBPDE2APDE10AMETMEN1
SCHEMBL15412490 0.69 POLB (0.41) POLBPDE2APDE10AMETKDM4E
SCHEMBL16611767 0.69 KDM4E (0.44) POLBPDE2APDE10AMEN1KMT2A
SCHEMBL15412786 0.69 POLB (0.43) POLBPDE2APDE10AMETKDM4E
SCHEMBL15412563 0.69 POLB (0.39) POLBPDE2APDE10AMETSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL NR4A1, NR2C2, NR0B1 POLB 4737/4885AGPAT2 2563/4885PDE2A 3420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback